Format

Send to

Choose Destination
Indian J Pathol Microbiol. 2020 Feb;63(Supplement):S70-S80. doi: 10.4103/IJPM.IJPM_832_19.

Role of immunohistochemistry in gynec oncopathology including specific diagnostic scenarios with associated treatment implications.

Author information

1
Department of Surgical Pathology, Tata Memorial Centre, HBNI University, Mumbai, Maharashtra, India.

Abstract

Over the years, immunohistochemistry has emerged as a powerful tool for a more precise diagnosis of certain tumors in gynecologic oncopathology and resolving certain diagnostic dilemmas with significant treatment implications. Certain specific immunohistochemical (IHC) markers have been useful in the more correct identification of rare tumors, characterized by specific molecular signatures. Immunohistochemistry has also been useful in the identification of underlying genetic events, characterizing various tumors, as well as precancerous lesions. This review will focus upon the judicious application of various IHC antibody markers in gynec oncopathology, including authors' experience during "sign-outs" and especially during interaction with other oncology colleagues within the institutional disease management group. The updated references were retrieved from PubMed.

KEYWORDS:

Diagnostic dilemmas in gynec pathology; gynec oncopathology; immunohistochemistry

PMID:
32108634
DOI:
10.4103/IJPM.IJPM_832_19
Free full text

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd
Loading ...
Support Center